Detailed price information for Enanta Pharmaceutica (ENTA-Q) from The Globe and Mail including charting and trades.
Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, announces today that Jay R. Luly, Ph.D., age 70, will retire as President and Chief Executive Officer, by February 1, 2027 following 23 years of leadership with the Company. Dr. Luly will continue to...
Detailed price information for Enanta Pharmaceutica (ENTA-Q) from The Globe and Mail including charting and trades.
WATERTOWN, Mass., September 01, 2026--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that members of management will participate in two investor conferences in September:
This is the newest page. Registered accounts read further back.